Recital 35, Directive (EU) 2001/83

In forcecited 7×

It is necessary to exercise control over the entire chain of distribution of medicinal products, from their manufacture or import into the Community through to supply to the public, so as to guarantee that such products are stored, transported and handled in suitable conditions. The requirements which must be adopted for this purpose will considerably facilitate the withdrawal of defective products from the market and allow more effective efforts against counterfeit products.

  • Judgment of the Court (Second Chamber), 28 June 2012. Fabio Caronna.Decision

    Recitals 2 to 5 and 35 and 36 of the Directive are worded as follows: The essential aim of any rules governing the production, distribution and use of medicinal products must be to safeguard public health. However, this objective must be …

    28 Jun 2012 · 62011CJ0007

  • Judgment of the Court (Third Chamber) of 16 July 2015. Abcur AB v Apoteket Farmaci AB and Apoteket AB.Decision

    Furthermore, recital 35 in the preamble to Directive 2001/83 refers to the necessity of exercising control over the entire chain of distribution of medicinal products, from their manufacture or import into the EU through to supply to the …

    16 Jul 2015 · 62013CJ0544

  • Opinion of Advocate General Saugmandsgaard Øe delivered on 25 July 2018. Novartis Farma SpA v Agenzia Italiana del Farmaco (AIFA) and OthersDecision

    With that in mind, recital 35 of Directive 2001/83 indicates that the directive seeks to exercise control over the entire chain of distribution of medicinal products, from their manufacture through to supply to the public (whilst the …

    25 Jul 2018 · 62017CC0029

  • Judgment of the Court (First Chamber) of 21 November 2018. Novartis Farma SpA v Agenzia Italiana del Farmaco (AIFA) and Others.Decision

    Recitals 2 and 35 of Directive 2001/83 state: The essential aim of any rules governing the production, distribution and use of medicinal products must be to safeguard public health. … It is necessary to exercise control over the entire …

    21 Nov 2018 · 62017CJ0029

  • Opinion of Advocate General Sharpston delivered on 31 January 2013. Novartis Pharma GmbH v Apozyt GmbH.Decision

    According to recital 35, ‘it is necessary to exercise control over the entire chain of distribution of medicinal products, from their manufacture or import into the Community through to supply to the public’.

    31 Jan 2013 · 62011CC0535

  • Opinion of Advocate General Pikamäe delivered on 16 March 2023. Apotheke B. v Bundesamt für Sicherheit im Gesundheitswesen (BASG).Decision

    Article 77(6) forms part of the rules governing the wholesale distribution of medicinal products for human use laid down in Title VII of Directive 2001/83 and contributes to the attainment of the objectives pursued by that directive, in …

    16 Mar 2023 · 62022CC0047

  • Opinion of Advocate General Bot delivered on 12 June 2019. VIPA Kereskedelmi és Szolgáltató Kft. v Országos Gyógyszerészeti és Élelmezés-egéDecision

    It is apparent from all the foregoing that, in my view, the national legislation at issue is justified, in essence, by the need to monitor safety and quality standards in the retail supply of medicinal products, in line with the objective …

    12 Jun 2019 · 62018CC0222